Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback & Yong Poovorawan. (2023) Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines. Expert Review of Vaccines 22:1, pages 620-628.
Read now
Read now
Articles from other publishers (2)
Mostafa Enayatrad, Sepideh Mahdavi, Roqayeh Aliyari, Sajad Sahab-Negah, Sairan Nili, Mohammad Fereidouni, Parvin Mangolian Shahrbabaki, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Reza Chaman, Hamid Sharifi & Mohammad Hassan Emamian. (2023) Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system. BMC Infectious Diseases 23:1.
Crossref
Crossref
Irene S Gabashvili. (2022) The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups. JMIR Formative Research 6:11, pages e41914.
Crossref
Crossref